
Retatrutide 30mg + Tirzepatide 30mg
The new RT Mix 30/30 — Retatrutide 30mg and Tirzepatide 30mg combined into one pre-filled cartridge.
The newest addition to our pre-filled cartridge range: Retatrutide 30mg and Tirzepatide 30mg combined into one pre-filled cartridge. Developed in response to client feedback — clients wanted the benefits of Retatrutide while also experiencing the stronger, more consistent appetite control they had come to expect from Tirzepatide. So we listened, and built RT Mix 30/30.
Retatrutide works differently because it activates three receptors — GLP-1, GIP and glucagon — while tirzepatide activates GLP-1 and GIP. Appetite suppression is only one part of the picture: some clients see changes in body weight and body composition even while still experiencing food thoughts or cravings. That's exactly why feedback matters to us, and it's what led to this new formulation. The new RT Mix 30/30 combines the different mechanisms of both compounds into one product, with a new pH profile — one of the formulation differences in this new batch. Clients using the new formulation have already reported stronger appetite suppression compared with their experience on previous batches. Contact us for product-specific details before ordering.
Please contact Peak Protocol for product-specific guidance.
Subcutaneous cartridge injection with site rotation.
Refrigerate at 2–8 °C. Protect from light. Do not freeze.
The R2,999 launch special runs until 31 October 2026. The regular price is R3,800.
Each cartridge contains Retatrutide 30mg and Tirzepatide 30mg in a new formulation with a different pH profile from our previous RT Mix batches.
If you're currently using Retatrutide and feel like your appetite response isn't what you expected, this is for you. It was developed directly from client feedback for exactly that reason.